{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T07:40:15Z","timestamp":1683877215266},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Gastro"],"published-print":{"date-parts":[[2002,3]]},"DOI":"10.1007\/s11938-002-0059-1","type":"journal-article","created":{"date-parts":[[2007,6,7]],"date-time":"2007-06-07T06:26:39Z","timestamp":1181197599000},"page":"125-131","source":"Crossref","is-referenced-by-count":1,"title":["Uninvestigated dyspepsia"],"prefix":"10.1007","volume":"5","author":[{"given":"Uri","family":"Ladabaum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William D.","family":"Chey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"59_CR1","first-page":"299","volume-title":"The Functional Gastrointestinal Disorders","author":"NJ Talley","year":"2000","unstructured":"Talley NJ, Stanghellini V, Heading RC, et al.: Functional gastroduodenal disorders. In The Functional Gastrointestinal Disorders, edn 2. Edited by Drossman DA. McLean, VA: Degnon Associates; 2000:299\u2013350. An excellent reference reflecting the efforts of international working teams. The book includes thorough literature reviews, proposed definitions for the functional gastrointestinal disorders, and recommendations for future research.","edition":"edn 2"},{"key":"59_CR2","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3109\/00365529708996530","volume":"32","author":"PG Farup","year":"1997","unstructured":"Farup PG, Wetterhus S, Osnes M, et al.: Ranitidine effectively relieves symptoms in a subset of patients with functional dyspepsia. Scand J Gastroenterol 1997, 32:755\u2013759.","journal-title":"Scand J Gastroenterol"},{"key":"59_CR3","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1080\/003655299750026029","volume":"34","author":"PG Farup","year":"1999","unstructured":"Farup PG, Hovde O, Torp R, et al.: Patients with functional dyspepsia responding to omeprazole have a characteristic gastro-oesophageal reflux pattern. Scand J Gastroenterol 1999, 34:575\u2013579.","journal-title":"Scand J Gastroenterol"},{"key":"59_CR4","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S0140-6736(94)92023-0","volume":"343","author":"P Bytzer","year":"1994","unstructured":"Bytzer P, Hansen JM, Schaffalitzky de Muckadell OB: Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia. Lancet 1994, 343:811\u2013816.","journal-title":"Lancet"},{"key":"59_CR5","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S0140-6736(00)02553-8","volume":"356","author":"AT Lassen","year":"2000","unstructured":"Lassen AT, Pedersen FM, Bytzer P, et al.: Helicobacter pylori test-and-eradicate versus prompt endoscopy for management of dyspeptic patients: a randomised trial. Lancet 2000, 356:455\u2013460. Important randomized, controlled study of alternative strategies to manage uninvestigated dyspepsia.","journal-title":"Lancet"},{"key":"59_CR6","doi-asserted-by":"crossref","unstructured":"Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group. Gut 1997, 41:8\u201313.","DOI":"10.1136\/gut.41.1.8"},{"key":"59_CR7","doi-asserted-by":"crossref","unstructured":"American Gastroenterological Association medical position statement: Evaluation of dyspepsia. Gastroenterology 1998, 114:579\u2013558.","DOI":"10.1016\/S0016-5085(98)70541-4"},{"issue":"suppl 12","key":"59_CR8","first-page":"S3","volume":"162","author":"SJ Veldhuyzen van Zanten","year":"2000","unstructured":"Veldhuyzen van Zanten SJ, Flook N, Chiba N, et al.: An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group. CMAJ 2000, 162(suppl 12):S3\u201323.","journal-title":"CMAJ"},{"key":"59_CR9","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1001\/archinte.160.9.1285","volume":"160","author":"WL Peterson","year":"2000","unstructured":"Peterson WL, Fendrick AM, Cave DR, et al.: Helicobacter pylori-related disease: guidelines for testing and treatment. Arch Intern Med 2000, 160:1285\u20131291.","journal-title":"Arch Intern Med"},{"key":"59_CR10","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1742-1241.1999.tb11765.x","volume":"53","author":"R Jones","year":"1999","unstructured":"Jones R, Tait C, Sladen G, et al.: A trial of a test-andtreat strategy for Helicobacter pylori positive dyspeptic patients in general practice. Int J Clin Pract 1999, 53:413\u2013416.","journal-title":"Int J Clin Pract"},{"key":"59_CR11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/gut.45.1.15","volume":"45","author":"AO Quartero","year":"1999","unstructured":"Quartero AO, Post MW, Numans ME, et al.: What makes the dyspeptic patient feel ill? A cross sectional survey of functional health status, Helicobacter pylori infection, and psychological distress in dyspeptic patients in general practice. Gut 1999, 45:15\u201319.","journal-title":"Gut"},{"key":"59_CR12","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/S0140-6736(00)02236-4","volume":"355","author":"P Moayyedi","year":"2000","unstructured":"Moayyedi P, Feltbower R, Brown J, et al.: Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Leeds HELP Study Group. Lancet 2000, 355:1665\u20131669.","journal-title":"Lancet"},{"key":"59_CR13","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1136\/bmj.321.7262.659","volume":"321","author":"P Moayyedi","year":"2000","unstructured":"Moayyedi P, Soo S, Deeks J, et al.: Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group. BMJ (Clinical Research ed) 2000, 321:659\u2013664.","journal-title":"BMJ (Clinical Research ed)"},{"key":"59_CR14","doi-asserted-by":"crossref","first-page":"361","DOI":"10.7326\/0003-4819-134-5-200103060-00008","volume":"134","author":"L Laine","year":"2001","unstructured":"Laine L, Schoenfeld P, Fennerty MB: Therapy for Helicobacter pylori in patients with nonulcer dyspepsia. A meta-analysis of randomized, controlled trials. Ann Intern Med 2001, 134:361\u2013369.","journal-title":"Ann Intern Med"},{"key":"59_CR15","first-page":"CD001961","volume":"2","author":"BC Delaney","year":"2000","unstructured":"Delaney BC, Innes MA, Deeks J, et al.: Initial management strategies for dyspepsia. Cochrane Database Sys Rev 2000, 2:CD001961. A recent systematic review of 10 studies evaluating the effectiveness of PPIs, H2RAs, antacids, and early endoscopy in patients with uninvestigated dyspepsia.","journal-title":"Cochrane Database Sys Rev"},{"key":"59_CR16","first-page":"541","volume":"11","author":"RH Jones","year":"1997","unstructured":"Jones RH, Baxter G: Lansoprazole 30 mg daily versus ranitidine 150 b.d. in the treatment of acid-related dyspepsia in general practice 1997, 11:541\u2013546.","journal-title":"Lansoprazole 30 mg daily versus ranitidine 150 b.d. in the treatment of acid-related dyspepsia in general practice"},{"key":"59_CR17","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1046\/j.1365-2036.1998.00410.x","volume":"12","author":"NJ Talley","year":"1998","unstructured":"Talley NJ, Meineche-Schmidt V, Pare P, et al.: Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Therap 1998, 12:1055\u20131065.","journal-title":"Aliment Pharmacol Therap"},{"key":"59_CR18","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1046\/j.1365-2036.1999.00584.x","volume":"13","author":"NJ Talley","year":"1999","unstructured":"Talley NJ, Axon A, Bytzer P, et al.: Management of uninvestigated and functional dyspepsia: a working party report for the World Congress of Gastroenterology 1998. Aliment Pharm Ther 1999, 13:1135\u20131148.","journal-title":"Aliment Pharm Ther"},{"key":"59_CR19","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S0889-8553(05)70130-8","volume":"29","author":"JE Everhart","year":"2000","unstructured":"Everhart JE: Recent developments in the epidemiology of Helicobacter pylori. Gastroenterol Clin N Am 2000, 29:559\u2013578.","journal-title":"Gastroenterol Clin N Am"},{"key":"59_CR20","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/infdis\/174.5.1120","volume":"174","author":"MA Staat","year":"1996","unstructured":"Staat MA, Kruszon-Moran D, McQuillan GM, Kaslow RA: A population-based serologic survey of Helicobacter pylori infection in children and adolescents in the United States. J Infect Dis 1996, 174:1120\u20131123.","journal-title":"J Infect Dis"},{"key":"59_CR21","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1001\/archinte.157.13.1489","volume":"157","author":"S Munnangi","year":"1997","unstructured":"Munnangi S, Sonnenberg A: Time trends of physician visits and treatment patterns of peptic ulcer disease in the United States. Arch Int Med 1997, 157:1489\u20131494.","journal-title":"Arch Int Med"},{"key":"59_CR22","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1136\/gut.43.3.327","volume":"43","author":"HB el-Serag","year":"1998","unstructured":"el-Serag HB, Sonnenberg A: Opposing time trends of peptic ulcer and reflux disease. Gut 1998, 43:327\u2013333.","journal-title":"Gut"},{"key":"59_CR23","first-page":"1403","volume":"87","author":"TJ Borody","year":"1992","unstructured":"Borody TJ, Brandl S, Andrews P, et al.: Helicobacter pylori-negative gastric ulcer. Am J Gastroenterol 1992, 87:1403\u20131406.","journal-title":"Am J Gastroenterol"},{"key":"59_CR24","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1111\/j.1572-0241.1999.01214.x","volume":"94","author":"AA Ciociola","year":"1999","unstructured":"Ciociola AA, McSorley DJ, Turner K, et al.: Helicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower than previously estimated. Am J Gastroenterol 1999, 94:1834\u20131840.","journal-title":"Am J Gastroenterol"},{"key":"59_CR25","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/j.1572-0241.1998.167_b.x","volume":"93","author":"S Jyotheeswaran","year":"1998","unstructured":"Jyotheeswaran S, Shah AN, Jin HO, et al.: Prevalence of Helicobacter pylori in peptic ulcer patients in greater Rochester, NY: is empirical triple therapy justified? Am J Gastroenterol 1998, 93:574\u2013578.","journal-title":"Am J Gastroenterol"},{"key":"59_CR26","first-page":"A836","volume":"96","author":"WD Chey","year":"2001","unstructured":"Chey WD, Ladabaum U, Fendrick AM, Scheiman JM: Cost-effectiveness of empiric PPI therapy vs. test and treat in uninvestigated dyspepsia: impact of decreasing H. pylori prevalence and increasing non-H. pylori ulcers. Am J Gastroenterol 2001, 96:A836.","journal-title":"Am J Gastroenterol"},{"key":"59_CR27","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1056\/NEJMoa001999","volume":"345","author":"N Uemura","year":"2001","unstructured":"Uemura N, Okamoto S, Yamamoto S, et al.: Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001, 345:784\u2013789.","journal-title":"N Engl J Med"},{"key":"59_CR28","unstructured":"Physicians\u2019 Desk Reference OnLine. Medical Economics Company, Inc; 2002. URL: www.pdr.net. Accessed January 27, 2002."},{"key":"59_CR29","unstructured":"AHFS Drug Information 2001. Besthesda, MD: American Society of Health-System Pharmacists; 2001."},{"key":"59_CR30","unstructured":"Drug Topics Red Book. Montvale, NJ: Medical Economics Company, Inc.; 2001."},{"key":"59_CR31","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s11938-999-0057-7","volume":"2","author":"WD Chey","year":"1999","unstructured":"Chey WD: Helicbacter pylori. Curr Treat Options Gastroenterol 1999, 2:171\u2013181.","journal-title":"Curr Treat Options Gastroenterol"}],"container-title":["Current Treatment Options in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-002-0059-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11938-002-0059-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-002-0059-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-002-0059-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T07:26:38Z","timestamp":1683876398000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11938-002-0059-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,3]]}},"alternative-id":["59"],"URL":"https:\/\/doi.org\/10.1007\/s11938-002-0059-1","relation":{},"ISSN":["1092-8472","1534-309X"],"issn-type":[{"value":"1092-8472","type":"print"},{"value":"1534-309X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,3]]}}}